Compare KNSA & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KNSA | VRNS |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.3B |
| IPO Year | 2018 | 2013 |
| Metric | KNSA | VRNS |
|---|---|---|
| Price | $79.55 | $49.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 24 |
| Target Price | ★ $98.00 | $51.32 |
| AVG Volume (30 Days) | 408.7K | ★ 1.5M |
| Earning Date | 10-27-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | $270,288,000.00 |
| Revenue This Year | $46.66 | $18.33 |
| Revenue Next Year | $22.90 | $18.63 |
| P/E Ratio | $291.67 | ★ N/A |
| Revenue Growth | ★ 60.09 | 24.35 |
| 52 Week Low | $35.53 | $19.70 |
| 52 Week High | $82.94 | $63.80 |
| Indicator | KNSA | VRNS |
|---|---|---|
| Relative Strength Index (RSI) | 60.46 | 63.91 |
| Support Level | $73.81 | $44.40 |
| Resistance Level | $81.42 | N/A |
| Average True Range (ATR) | 2.60 | 1.52 |
| MACD | 0.30 | 0.07 |
| Stochastic Oscillator | 86.28 | 95.41 |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.